Colorectal Cancer Awareness

March is Colorectal Cancer Awareness Month!
Did you know? Colorectal cancer is the third most common cancer worldwide. It is the second leading cause of cancer-related deaths worldwide. In 2022, more than 1.9 million new cases were diagnosed and 904,019 deaths attributed to CRC.

When colorectal cancer is detected early (localized stage), the 5-year survival rate is approximately 90%. However, only about 40% of colorectal cancers are diagnosed at this early stage, highlighting the importance of regular screening and early intervention.

At Diagnostic BioSystems Inc., we empower pathologists with advanced IHC solutions that provide accurate and reliable insights into colorectal cancer diagnostics. Our high-quality antibodies and reagents support precise tissue analysis, helping healthcare professionals make informed treatment decisions.

Early Screening Saves Lives! Encourage loved ones to get screened, especially if they’re over 50 or have a family history of colorectal cancer.